Hydrazine sulfate and preneoplastic exfoliated cells.
Animal experiments and most encouraging clinical trials substantiate that hydrazine sulfate inhibits the paraneoplastic systemic energy-losing cycle. The question arises: could hydrazine sulfate offer an alternative to surgery for patients with preneoplastic exfoliated cells? Research data indicate that clinical trials are appropriate.
D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D006834:Hydrazines / Q000494:pharmacology / Q000627:therapeutic use*; D011230:Precancerous Conditions / Q000188:drug therapy*
D006834:Hydrazines